Extranodal NK-T-cell lymphoma historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 14: Line 14:
* The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as [[Wegener's granulomatosis|Wegener's Granulomatosis]] was ruled out.
* The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as [[Wegener's granulomatosis|Wegener's Granulomatosis]] was ruled out.
*In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the [[Leukemia|leukemic disease]].<ref name="SawadaInoue2018">{{cite journal|last1=Sawada|first1=Akihisa|last2=Inoue|first2=Masami|title=Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders|journal=Frontiers in Pediatrics|volume=6|year=2018|issn=2296-2360|doi=10.3389/fped.2018.00334}}</ref>
*In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the [[Leukemia|leukemic disease]].<ref name="SawadaInoue2018">{{cite journal|last1=Sawada|first1=Akihisa|last2=Inoue|first2=Masami|title=Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders|journal=Frontiers in Pediatrics|volume=6|year=2018|issn=2296-2360|doi=10.3389/fped.2018.00334}}</ref>
* Reanalysis of stored slides of 1965 revealed an [[Immunophenotyping|immunophenotype]] typical of [[NK cell]] which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK304353/ |title=EPSTEIN-BARR VIRUS - Biological Agents - NCBI Bookshelf |format= |work= |accessdate=2019-10-28}}
* Reanalysis of stored slides of 1965 revealed an [[Immunophenotyping|immunophenotype]] typical of [[NK cell]] which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.
* Biopsy specimen collected in 1998 and 2002 contained [[EBV]] [[virus]] encoded [[RNA]] transcripts and then diagnosed as a natural-killer-cell lymphoma.
* Biopsy specimen collected in 1998 and 2002 contained [[EBV]] [[virus]] encoded [[RNA]] transcripts and then diagnosed as a natural-killer-cell lymphoma.



Revision as of 17:17, 28 October 2019

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma historical perspective

CDC on Extranodal NK-T-cell lymphoma historical perspective

Extranodal NK-T-cell lymphoma historical perspective in the news

Blogs on Extranodal NK-T-cell lymphoma historical perspective

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma. The natural history of extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "rhinitis gangrenosa progressiva". Since the lesions usually was in midline and was aggressive and lethal, the term "lethal midline granuloma (LMG)" was used. First known case of natural-killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.

Historical Perspective

Discovery

  • Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma.[1]
  • The natural history of extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "rhinitis gangrenosa progressiva".[2]
  • Since the lesions usually was in midline and was aggressive and lethal, the term "lethal midline granuloma (LMG)" was used.[3]
  • First known case of natural-killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.[4]
  • Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified sarcoma.
  • The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
  • In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the leukemic disease.[5]
  • Reanalysis of stored slides of 1965 revealed an immunophenotype typical of NK cell which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.
  • Biopsy specimen collected in 1998 and 2002 contained EBV virus encoded RNA transcripts and then diagnosed as a natural-killer-cell lymphoma.

References

  1. Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T (2019). "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress". Front Pediatr. 7: 141. doi:10.3389/fped.2019.00141. PMC 6476925. PMID 31041299.
  2. McBride P (1991). "Photographs of a case of rapid destruction of the nose and face. 1897". J Laryngol Otol. 105 (12): 1120. doi:10.1017/s0022215100118407. PMID 1787378.
  3. Aozasa, Katsuyuki; Takakuwa, Tetsuya; Hongyo, Tadashi; Yang, Woo-Ick (2008). "Nasal NK/T-cell lymphoma: epidemiology and pathogenesis". International Journal of Hematology. 87 (2): 110–117. doi:10.1007/s12185-008-0021-7. ISSN 0925-5710.
  4. Schrader C, Janssen D, Kneba M, Lennert K (2004). "A 38-year history of natural-killer-cell lymphoma". N Engl J Med. 350 (4): 418–9. doi:10.1056/NEJM200401223500423. PMID 14736941.
  5. Sawada, Akihisa; Inoue, Masami (2018). "Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00334. ISSN 2296-2360.


Template:WikiDoc Sources